An Oral Mucositis Prevention/Treatment Protocol for Blood and Marrow Stem Cell Transplantation: A Research Utilization Project

2.50
Hdl Handle:
http://hdl.handle.net/10755/165751
Category:
Abstract
Type:
Presentation
Title:
An Oral Mucositis Prevention/Treatment Protocol for Blood and Marrow Stem Cell Transplantation: A Research Utilization Project
Author(s):
Brown, Capt. Carlton
Author Details:
Capt. Carlton Brown, Walter Reed Army Medical Center, Washington, DC, USA
Abstract:
Mucositis is a painful, debilitating complication of patients receiving high-dose chemotherapy for blood and marrow stem cell transplant (BMSCT). Ablating chemotherapy kills not only cancer cells, but all fast-growing cells as well. Damage to the oral mucosal cells can leave patients with extremely painful open oral and esophageal sores which make eating, drinking, or talking difficult. Patients undergoing BMSCT at Walter Reed Army Medical Center (WRAMC) presented with similarly high numbers of severe mucositis. Between June 2000 and June 2001, 57% of BMSCT patients reported severe mucositis. A needs assessment of nurses working on the inpatient bone marrow transplant unit at WRAMC revealed that mucositis was the second most distressing adverse symptom related to BMSCT. Problem: At WRAMC, nurses use several assessment tools to quantify the degree of stomatitis, but no standardized tool is in use and there is a lack of formalized, standard patient education. Secondly, while numerous agents (hydrogen peroxide, saline/baking soda rinse, or other commercial mouth care products) are used, no standard oral hygiene regimen is used during treatment. The Iowa Model of Research Utilization will be utilized to guide the process of developing a protocol for mucositis. This poster presentation will share the research utilization process plus present research findings related to mucositis. Specific aims include: Review current research and practice literature about oral mucositis prevention/treatment; develop a prevention-based patient program for oral mucositis; implement the oral mucositis prevention/treatment program by educating patients, family, and nursing staff; conduct follow-up outcomes evaluation concerning oral mucositis incidence and severity. Outcome: Decrease severity of oral mucositis in patients receiving BMSCT; and increase patient and staff education about oral mucositis prevention/treatment. Significance to cancer nursing/quality cancer nursing: Oral complications cause significant problems for BMSCT patients. Quality of life is diminished in patients suffering from painful moderate to severe mucositis. Oncology nurses are in an excellent position to implement evidenced-based research into a standardized mucositis prevention/treatment protocol. Because current practices across the country have many differences and few similarities, a uniform standardized mucositis protocol that is available to any cancer nurse also has significant potential to improve cancer nursing nationally.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleAn Oral Mucositis Prevention/Treatment Protocol for Blood and Marrow Stem Cell Transplantation: A Research Utilization Projecten_GB
dc.contributor.authorBrown, Capt. Carltonen_US
dc.author.detailsCapt. Carlton Brown, Walter Reed Army Medical Center, Washington, DC, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/165751-
dc.description.abstractMucositis is a painful, debilitating complication of patients receiving high-dose chemotherapy for blood and marrow stem cell transplant (BMSCT). Ablating chemotherapy kills not only cancer cells, but all fast-growing cells as well. Damage to the oral mucosal cells can leave patients with extremely painful open oral and esophageal sores which make eating, drinking, or talking difficult. Patients undergoing BMSCT at Walter Reed Army Medical Center (WRAMC) presented with similarly high numbers of severe mucositis. Between June 2000 and June 2001, 57% of BMSCT patients reported severe mucositis. A needs assessment of nurses working on the inpatient bone marrow transplant unit at WRAMC revealed that mucositis was the second most distressing adverse symptom related to BMSCT. Problem: At WRAMC, nurses use several assessment tools to quantify the degree of stomatitis, but no standardized tool is in use and there is a lack of formalized, standard patient education. Secondly, while numerous agents (hydrogen peroxide, saline/baking soda rinse, or other commercial mouth care products) are used, no standard oral hygiene regimen is used during treatment. The Iowa Model of Research Utilization will be utilized to guide the process of developing a protocol for mucositis. This poster presentation will share the research utilization process plus present research findings related to mucositis. Specific aims include: Review current research and practice literature about oral mucositis prevention/treatment; develop a prevention-based patient program for oral mucositis; implement the oral mucositis prevention/treatment program by educating patients, family, and nursing staff; conduct follow-up outcomes evaluation concerning oral mucositis incidence and severity. Outcome: Decrease severity of oral mucositis in patients receiving BMSCT; and increase patient and staff education about oral mucositis prevention/treatment. Significance to cancer nursing/quality cancer nursing: Oral complications cause significant problems for BMSCT patients. Quality of life is diminished in patients suffering from painful moderate to severe mucositis. Oncology nurses are in an excellent position to implement evidenced-based research into a standardized mucositis prevention/treatment protocol. Because current practices across the country have many differences and few similarities, a uniform standardized mucositis protocol that is available to any cancer nurse also has significant potential to improve cancer nursing nationally.en_GB
dc.date.available2011-10-27T12:24:15Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:24:15Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.